Selected Grants
Congenital Athymia Patient Registry
Clinical TrialPrincipal Investigator · Awarded by Enzyvant · 2022 - 2027Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026Developing a National Registry for Female Carriers of X-linked Chronic Granulomatous Disease: Improving Recognition, Diagnosis, and Treatment
ResearchCollaborator · Awarded by American College of Allergy, Asthma & Immunology · 2024 - 2026Duke Center for Advancement of Child Health (CAtCH).
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025Congenital Athymia Patient Registry
Clinical TrialPrincipal Investigator · Awarded by Enzyvant · 2022 - 2027Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026Developing a National Registry for Female Carriers of X-linked Chronic Granulomatous Disease: Improving Recognition, Diagnosis, and Treatment
ResearchCollaborator · Awarded by American College of Allergy, Asthma & Immunology · 2024 - 2026Duke Center for Advancement of Child Health (CAtCH).
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025Research Training in Allergy and Clinical Immunology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2000 - 2025Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2024LOC-IMPAACT Leadership Group
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2020 - 2024Duke Resident Physician-Scientist Program - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2023Consequences of marijuana use on inflammatory pathways in HIV-infected youth
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2023Impact of maternal HIV infection on immune priming of their uninfected infants
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2023Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16
Clinical TrialPrincipal Investigator · Awarded by ADMA Biologics · 2020 - 2022Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiences
Public ServicePrincipal Investigator · Awarded by Jeffrey Modell Foundation · 2016 - 2022Consequences of marijuana use on inflammatory pathways impacting neurocognitive function in Youth with HIV (YWH)
ResearchCollaborator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2022LOC-IMPAACT Leadership Group
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2014 - 2020A Phase 3, Multinational, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and Pharmacokinetics of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% in Adults and Children with Primary Immunodeficiency Diseases.
Clinical TrialPrincipal Investigator · Awarded by ProMetic Life Sciences Inc. · 2017 - 2020Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects with Primary Immunodeficiency Diseases
Clinical TrialPrincipal Investigator · Awarded by Baxalta, Inc. · 2019 - 2020ATN 071, Neurocognitive Assessment in Youth Initiating HAART, and its sub-study ATN 101, Assessment of Inflammatory Markers Associated with Neurocognitive Impairment in HIV-infected Adolescents
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2019An open-label, multi-center study to evaluate the 1 safety and phannacokinetics of IGSC 20% . administered for 6 months in subjects with primary immunodeficiency
Clinical TrialPrincipal Investigator · Awarded by Grifols USA, LLC · 2016 - 2019Effect of breast feeding on immunologic priming in young infants
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2018Office of AIDS Research Strategic Initiative to Develop and Overarching Research Agenda for Children and Youth
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2017 - 2017ATN Coordinating Center
ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2014 - 2017Substance Use and Immunity in HIV+ Adolescents by Systems Biology
ResearchPrincipal Investigator · Awarded by University of Florida · 2014 - 2016Asthma Clinical Research Center of the American Lung Association
ResearchCo Investigator · Awarded by American Lung Association · 2009 - 2016Substance Abuse and Immunity in HIV+ Adolescents by Systems Biology
ResearchPrincipal Investigator · Awarded by University of Florida · 2014 - 2015ATN Coordinating Center
ResearchPrincipal Investigator · Awarded by University of Alabama · 2013 - 2014External Relationships
- Chinook Therapeutics
- Sumitomo Pharma America, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.